An opinion piece in The Atlantic about the $3 billion settlement against GlaxoSmithKline makes the point that even a relatively large financial penalty is unlikely to stop a company that still makes a profit from illegal activities. The solution, The Atlantic says, is to change a system that essentially allows companies to monitor themselves.
The British drugmaker’s agreement with the U.S. Justice Department to pay $3 billion in criminal and civil ...
continue reading...
Johnson & Johnson will reportedly pay a settlement in the neighborhood of $2 billion to settle federal charges that the company used illegal tactics in marketing its antipsychotic drug Risperdal.
The federal probe prompting that settlement included investigations into the company’s alleged kickbacks to Omnicare Inc., a company that dispenses drugs at nursing homes, to boost sales of certain medicines.
In light of Johnson & Johnson’s enormous profits, some observers have questioned ...
continue reading...
Dr. Drew Pinsky – well-known as TV and radio host “Dr. Drew” – is dealing with criticism after court records revealed that he took $275,000 from GlaxoSmithKline for “services for Wellbutrin.”
GlaxoSmithKline recently agreed to a $3 billion settlement — the largest ever involving a pharmaceutical company – over the federal government’s charges that the company illegally marketed some of its medications.
Prosecutors allege that the British pharmaceutical giant’s tactics included paying ...
continue reading...GlaxoSmithKline has agreed to pay $3 billion in fines for fraudulently promoting medications for unapproved uses. According to a New York Times report, it’s the largest settlement ever leveled against a pharmaceutical company.
But the settlement doesn’t end the company’s legal disputes. Widespread lawsuits allege that GlaxoSmithKline and other manufacturers of antidepressants classified as selective serotonin reuptake inhibitors failed to adequately warn pregnant patients of studies linking the drugs to continue reading...
The U.S. Court of Appeals for the First Circuit has sided with a woman previously awarded $21.06 million in damages against the manufacturer Clinoril, which caused her permanent near blindness and skin burns over about 60 percent of her body in a condition known as Stevens-Johnson Syndrome, or SJS.
The May 2 decision regarding ...
continue reading...The Associated Press reported today that the United States government has agreed to pay $2.5 million to settle a case brought by the family of Robert Stevens, who died after being exposed to anthrax in 2001. Stevens was one of four people who died during the attacks. Seventeen other people were exposed to anthrax and became sick. According to ABC news, many still have lingering health problems attributed to the anthrax. Several other lawsuits were filed, but most have been ...
continue reading...
